Histological localization of Tissue Polypeptide Antigen (TPA) was studied by immunohistochemical technique as well as measurement of serum TPA levels by radioimmunoassay in various gynecological malignancies including uterine precancerous lesions and trophoblastic disease. Measurement of serum TPA levels in 75 patients revealed that serum levels and positive rates of TPA in invasive cancer were significantly higher than those in normal women, but those in precancerous lesions were low. In 82 cases, the overall positive rates for tissue TPA immunostaining was 49%. There was no definite difference between the histological types and progress of malignancy and the positive rate for tissue TPA staining. In all of 15 patients with positive TPA, s...
The clinical usefulness of tissue polypeptide antigen, galactosyltransferase II and pancreatic oncof...
The serum concentration of the cell proliferation marker TPS (tissue polypeptide-specific antigen) w...
The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patient...
Tissue polypeptide antigen (TPA) was studied in 242 sera and 165 tumor cell cytosols (both evaluatio...
Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Obj...
The study was designed to evaluate the significance of tissue polypeptide specific antigen (TPS) in ...
The purpose of this study was to determine the role of Tissue Polypeptide Antigen (TPA) immunostaini...
Summary: Tissue polypeptide antigen, measured by both a polyclonal antibody (TPA IRMA Prolifigen®) a...
Clinical trials have suggested that the serologic cytokera-tin tumor marker tissue polypeptide antig...
serum and urine, as an index to the presence of cancer. In the assay, serum, which is first absorbed...
Tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) were determined in the sera of 3...
TPS (tissue polypeptide specific antigen) is a well−documented tumor marker for epithelial malignanc...
Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative r...
Three hundred two patients with squamous cell carcinoma of the cervix had pretreatment measurement o...
Cancer antigen 125 (CA 125) is common to most epithelial ovarian tumors. Therefore, it is potentiall...
The clinical usefulness of tissue polypeptide antigen, galactosyltransferase II and pancreatic oncof...
The serum concentration of the cell proliferation marker TPS (tissue polypeptide-specific antigen) w...
The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patient...
Tissue polypeptide antigen (TPA) was studied in 242 sera and 165 tumor cell cytosols (both evaluatio...
Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Obj...
The study was designed to evaluate the significance of tissue polypeptide specific antigen (TPS) in ...
The purpose of this study was to determine the role of Tissue Polypeptide Antigen (TPA) immunostaini...
Summary: Tissue polypeptide antigen, measured by both a polyclonal antibody (TPA IRMA Prolifigen®) a...
Clinical trials have suggested that the serologic cytokera-tin tumor marker tissue polypeptide antig...
serum and urine, as an index to the presence of cancer. In the assay, serum, which is first absorbed...
Tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) were determined in the sera of 3...
TPS (tissue polypeptide specific antigen) is a well−documented tumor marker for epithelial malignanc...
Tissue polypeptide specific antigen (TPS) is a new tumor marker that indicates tumor proliferative r...
Three hundred two patients with squamous cell carcinoma of the cervix had pretreatment measurement o...
Cancer antigen 125 (CA 125) is common to most epithelial ovarian tumors. Therefore, it is potentiall...
The clinical usefulness of tissue polypeptide antigen, galactosyltransferase II and pancreatic oncof...
The serum concentration of the cell proliferation marker TPS (tissue polypeptide-specific antigen) w...
The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patient...